Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Astra discloses immunomodulatory peptides for oral administration

June 26, 1998

Aviron and CSL enter collaboration for FluMist

June 26, 1998

University of Pittsburgh researcher awarded grant to study dendritic cell use in transplantation

June 26, 1998

Group C meningococcal conjugate vaccine shown safe and immunogenic in phase II

June 25, 1998

Immunosuppressive, antiinflammatory and antitumor rapamycin derivatives

June 23, 1998

University of Pittsburgh awarded grant for dendritic cell research

June 22, 1998

DTaP-IPV nears approval in several European countries

June 22, 1998

SangStat receives U.S. patent covering multiple ciclosporin formulations

June 19, 1998

Vaccine carrier offered for licensing by biosyn Arzneimittel

June 19, 1998

Novel rapamycin derivatives patented by AHP

June 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...